
Pramipexole Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: ER tab: 0.375 mg, 0.75 mg, 1.5 mg, 3 mg, 4.5 mg; IR Tab: 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg
Reference Brands: Mirapex®(US), Sifrol® (EU)
Category: Antipsychotropic Drugs
Pramipexole is available in Tablets and strengths such as ER tab: 0.375 mg, 0.75 mg, 1.5 mg, 3 mg, 4.5 mg; IR Tab: 0.125 mg, 0.25 mg, 0.5 mg, 0.75 mg, 1 mg, 1.5 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Pramipexole is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Pramipexole can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Pramipexole is a dopamine agonist used in the treatment of Parkinson’s disease and restless legs syndrome (RLS). It is available in both immediate- and extended-release oral tablet forms with strengths ranging from 0.125 mg to 4.5 mg. Marketed under brands like Mirapex® in the US and Sifrol® in the EU, Pramipexole helps improve motor function and reduce symptoms in neurological disorders. Pharma B2B suppliers offer bulk procurement of Pramipexole from GMP-certified manufacturers, ensuring quality, regulatory compliance, and efficient global supply. Ideal for pharmacies, distributors, and hospital procurement across neurology and chronic care specialties.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Amisulpride
Strength:
5 mg/2 mL, 50 mg, 100 mg, 200 mg
Form: Tablets / injectable solutions
Reference Brands: Barhemsys (USA), Solian (EU)
View DetailsRisperidone Long-Acting Injection
Strength:
12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View DetailsZuclopenthixol Ong-Acting Im Injection (Depot)
Strength:
200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View DetailsZuclopenthixol Short-Acting Intramuscular Injection
Strength:
50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View DetailsQuick Response Guaranteed | Verified Suppliers